Kamada awarded $25M 3-year contract to supply kamrab, varizig in Latin America

Kamada (KMDA) announced that it was awarded a contract with an international organization for the supply of KAMRAB and VARIZIG in Latin America for 2025-2027. Total expected revenue under the three-year contract for both products is estimated to be approximately $25 million. The expected portion for the calendar year 2025 is incorporated into the Company’s recently announced 2025 revenue guidance.